Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China
Canada NewsWire BOSTON and BEIJING, Jan. 26, 2021/CNW/ —Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for
Read more